Gliclazide terecht eerste keus SU-derivaat voor de behandeling van type 2 diabetes mellitus?

Translated title of the contribution: Is gliclazide rightly the first choice SU-derivative for the treatment of type 2 diabetes mellitus?

Abel Thijs*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageDutch
JournalNederlands Tijdschrift voor Geneeskunde
Issue number27
Publication statusPublished - 1 Jan 2014

Cite this